Form 8-K - Current report:
SEC Accession No. 0001104659-25-022588
Filing Date
2025-03-11
Accepted
2025-03-11 16:45:42
Documents
15
Period of Report
2025-03-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm258808d1_8k.htm   iXBRL 8-K 32736
2 EXHIBIT 99.1 tm258808d1_ex99-1.htm EX-99.1 15198
6 GRAPHIC tm258808d2_ex99-1img002.jpg GRAPHIC 8538
  Complete submission text file 0001104659-25-022588.txt   239506

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nvax-20250310.xsd EX-101.SCH 3012
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20250310_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20250310_pre.xml EX-101.PRE 22357
17 EXTRACTED XBRL INSTANCE DOCUMENT tm258808d1_8k_htm.xml XML 3558
Mailing Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 25728285
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)